Core Laboratories Inc. (CLB) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$10.64 +2.31% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $10.66

Core Laboratories Inc. (CLB) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ β€’ SELL / AVOID Cap $477.2M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CLB Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is CLB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Core Laboratories Inc. (NYSE: CLB) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $10.64 (+2.31% 1D, market cap $477.2M). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 16/20. Across 211 tracked Energy issuers, CLB ranks #106 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does CLB compare to NGS and RNGR in the Energy sector?
β–Ό

Within the Energy sector (Oilfield Services/Equipment), CLB carries a Roarable D+ (58/100 RQD), trailing P/E of 16.1x, gross margin of 20.7%, and ROIC of 12.6%. By comparison, NGS (Natural Gas Services Group Inc.) holds a E grade (33/100 RQD, P/E 21.3x, ROIC 10.7%, cap $424.1M) and RNGR (Ranger Energy Services Inc. (Class A)) posts a D+ grade (53/100 RQD, P/E 29.4x, ROIC 4.2%, cap $361.3M). Among the 5-stock peer group, CLB leads on earnings multiple (16.1x) while CLB leads on capital efficiency (12.6% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CLB?
β–Ό

Per CLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001958086), Core Laboratories Inc. generated $526.5M in revenue (+0.5% YoY), $29.7M in net income, and $25.8M in free cash flow against $584.0M in total assets and $110.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $10.66 (+0.23%)🧬 Cannibal Buyback (-2.36% YoY Shares)βš™οΈ Cash Engine: 13/20 (C) β€’ 4.9% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY β€’ 52.7% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D+
025507510058
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ Β· Rk C-
Cash (13)Whales (5)SEC (13)Macro (11)CEO (16)
Each axis scored 0–20
12M PRICE TARGET CONE+0% Base Target
$21 Bull$11 Base$8 Bear
πŸ“¬ FREE CLB RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for CLB)Realized 20D OHLCV Swing Band: Β±8.3%
Deterministic 5-Pillar Attribution (58/100 Composite)
πŸ” WHY CLB SCORES 58/100 (D+) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (28% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy β€’ Cannibal Buyback (-2.36% YoY Shares)

β–² #2 Bullish Driver: Cash Engine Quality+13/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 4.9% FCF Margin ($25.8M FCF) & 20.7% Gross Margin

β–Ό #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
50
Grade C-$10.01+1.4% Next Q
Q2 (-2Q)
53
Grade C-$10.15+0.7% Next Q
Q3 (-1Q)
55
Grade C$10.22+4.1% Next Q
Current
58
Grade D+$10.64+0% Hist 90D Ξ±
Trajectory: C- (50) β†’ D+ (58)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the CLB Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 58/100 (D+) score, CLB faces multiple-compression risk if 16.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) β€” any gross margin slip below 18.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($10.95) or 200D SMA ($13.82) invalidates the momentum regime and cuts Target Base ($10.64) toward Bear Floor ($8.30).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CLBβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œCLB Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

CLB Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (CLB)

No recent open-market Form 4 cluster sales or emergency dumps flagged on CLB. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CLB)

  • βœ“Walkthrough of CLB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CLB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -22.79%β–Ό DESCENDING CHANNEL
2026-11-02O $10.49H $10.64L $10.40C $10.64VOL 1.04M
RES: $12.01SUP: $9.05SMA50: $10.95SMA200: $13.82
$17.04$14.89$12.75$10.61$8.46RES $12.01SUP $9.05$10.642026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CLB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.7%/yr Implied 5Y Growth

vs. +0.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CLB today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for CLB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CLB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CLB)

1. Head-to-Head Energy Peer Comparison (CLB vs. NGS, RNGR, NOA, ACDC)

Industry: Oilfield Services/Equipment (20 Tracked Issuers)

Across 211 tracked Energy securities in the Roarable RQD universe, Core Laboratories Inc. (CLB) ranks #106 by composite RQD confidence (58/100, grade D+) and #154 by equity capitalization ($477.2M). Within this direct 5-issuer industry benchmark cohort, CLB leads on earnings valuation at 16.1x trailing P/E, while CLB leads on capital efficiency and profitability with 12.6% ROIC and 20.7% gross margin. CLB currently leads its immediate peer cohort in composite quantitative strength at 58/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CLB ACTIVE
Core Laboratories Inc.
D+ 58/100 16.1x 20.7% 12.6% +2.31% $477.2M Benchmark Subject
NGS
Natural Gas Services Group Inc.
E 33/100 21.3x β€” 10.7% -1.46% $424.1M /ngs-vs-clb β†’
RNGR
Ranger Energy Services Inc. (Class A)
D+ 53/100 29.4x β€” 4.2% -1.44% $361.3M /rngr-vs-clb β†’
NOA
North American Construction Group Ltd. (no par)
D 49/100 β€” β€” β€” -4.39% $347.5M /noa-vs-clb β†’
ACDC
ProFrac Holding Corp. (Class A)
E 33/100 β€” β€” -11.4% +0.62% $883.3M /acdc-vs-clb β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001958086

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Laboratories Inc. (CLB) reported GAAP revenue of $526.5M (+0.5% vs. FY2024 revenue of $523.8M , and +3.3% cumulative change since FY2023) , GAAP net income of $29.7M, operating cash flow of $37.0M, and free cash flow of $25.8M (-42.0% YoY). On the balance sheet, CLB closed FY2025 with $584.0M in total assets against $110.3M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $526.5M $29.7M $37.0M $25.8M $584.0M $110.3M
FY2024 (FY) 2024-12-31 $523.8M $31.4M $56.4M $44.5M $585.1M $126.1M
FY2023 (FY) 2023-12-31 $509.8M $36.7M $24.8M $24.8M β€” β€”

3. CLB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CLB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Core Laboratories Inc. (NYSE: CLB) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $10.64 (+2.31% 1D, market cap $477.2M). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 16/20. Across 211 tracked Energy issuers, CLB ranks #106 in composite RQD confidence.

How does CLB compare to NGS and RNGR in the Energy sector?

Within the Energy sector (Oilfield Services/Equipment), CLB carries a Roarable D+ (58/100 RQD), trailing P/E of 16.1x, gross margin of 20.7%, and ROIC of 12.6%. By comparison, NGS (Natural Gas Services Group Inc.) holds a E grade (33/100 RQD, P/E 21.3x, ROIC 10.7%, cap $424.1M) and RNGR (Ranger Energy Services Inc. (Class A)) posts a D+ grade (53/100 RQD, P/E 29.4x, ROIC 4.2%, cap $361.3M). Among the 5-stock peer group, CLB leads on earnings multiple (16.1x) while CLB leads on capital efficiency (12.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CLB?

Per CLB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001958086), Core Laboratories Inc. generated $526.5M in revenue (+0.5% YoY), $29.7M in net income, and $25.8M in free cash flow against $584.0M in total assets and $110.3M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CLB trading relative to its 50-day, 200-day, and 52-week technical levels?

CLB last traded at $10.64 (+2.31% on volume of 880,196 shares), positioning the stock -2.83% below its 50-day simple moving average ($10.95) and -23.01% below its 200-day simple moving average ($13.82). Across its 52-week range of $9.13 to $20.36, CLB sits at the 13.4% percentile with a 14-day RSI of 50.5 (NEUTRAL RANGE) and an implied next-earnings move of Β±8.3% ($9.76 to $11.52).

CLB Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Are CLB insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies CLB leadership and institutional positioning as: HEAVY INSIDER & 13F ACCUMULATION.

ROARABLE RATING BRIEF β€’ RQD 58/100 (D+) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

CLB β€” Core Laboratories Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:36:02Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, CLB scores 58 out of 100, grading D+ with the verdict "Roarable Sell β€” Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine 13/20 (ROIC 12.6%; FCF yield 5.41%), Whale 13F Flow 5/20 (institutional accumulation and options positioning), Insider Conviction 16/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit 11/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet 13/20 (Altman Z 2.5; Piotroski F 6/9; Debt/Equity 0.41). For a prospective investor, the strongest pillar is insider conviction, which is the highest-scoring element, while institutional flow is the weakest at 5/20, signaling limited institutional accumulation in the source data. The cash-generation and balance-sheet pillars sit at mid-range scores, suggesting the business produces cash and carries moderate leverage without showing a clear margin of safety. The rating's overall tilt is negative, so the upside case rests mainly on insider signaling and any valuation re-rating, while the downside case reflects weak institutional support and a sector-sensitive, beta-1.0 profile. Valuation tradeoffs are visible in the multiples: a P/E (TTM) of 16.1 and EV/EBITDA of 8.6 are not distressed-level figures, yet the price sits near the lower part of its 52-week range, so investors weighing entry should consider whether the discount reflects fundamentals or sentiment.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
10.4$477.2M16.1158.60.650.39%1.0$9.13 - $20.3612.6%

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$526.5M$56.5M$29.7MN/A$25.8M$22.7M$110.3M
FY 2024$523.8M$58.6M$31.4MN/A$44.5M$19.2M$126.1M
FY 2023$509.8M$54.6M$36.7MN/A$24.8MN/AN/A

Per the market data, gross margin is 20.7%, operating margin 10.7%, and net margin 5.6%, with ROIC of 12.6%. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 6/9, and Debt/Equity is 0.41. Reported net income declined from $36.7M (FY 2023) to $31.4M (FY 2024) to $29.7M (FY 2025), while revenue rose modestly across the three periods. Debt declined from $126.1M to $110.3M over FY 2024–FY 2025, and cash increased from $19.2M to $22.7M.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts feed, the most recent items are: a Yahoo! Finance Canada market report (YELLOW, Market Wire), a Simply Wall St stock analysis (YELLOW, Market Wire), a Yahoo Finance report headlined around Q3 results and tightening margins (YELLOW, Market Wire), a TradingView report stating Q3 2026 results were in line with expectations (YELLOW, Market Wire), a GuruFocus item on a quarterly dividend of $0.01 (YELLOW, Market Wire), and a MarketBeat item reporting that a holder cut positions (RED, Risk Watch). The only RED-flagged item is the holdings-reduction report, which is the primary risk-watch signal in the feed. The margin-tightening headline is a second cautionary theme, while the in-line Q3 report and the dividend declaration are neutral-to-supportive. Per the Butterfly Supply-Chain Graph, no proprietary signals or supply-chain links are recorded for this issuer.

Open Questions

  • What specific products and end-markets drive CLB revenue, and how concentrated is its customer base?
  • What is the reported EPS for FY 2024 and FY 2025, given that the financial data lists EPS as N/A for these periods?
  • What drove the margin tightening referenced in the Q3 results headline, and is it expected to persist?
  • What are the cash and debt balances for FY 2023, which are listed as N/A in the financial data?
  • Which institutional holders increased or decreased positions, and what is the composition of insider and Congressional trading behind the insider-conviction pillar?

CLB Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Core Laboratories Inc. (CLB) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to CLB Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CLB Bull vs. Bear Conversation Board β€” What's Your Call at $10.64?

πŸ‚ 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CLB 🐻 50% BEARISH CONVICTION
1. Pick Your Side on CLB:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk βš–οΈ DEBATE HOST 🎯 Target: $11.23 (+8.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is CLB (D+ β€’ RQD 58/100) a Buy at $10.40?

Welcome to the CLB (Core Laboratories Inc.) Roar Pit. Current RQD Composite is 58/100 (Roarable Sell β€” Weak Fundamentals / Trim) in Oilfield Services/Equipment. Bulls point to capital efficiency (12.6% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $7.80 (-25.0%)
Spot @ $10.40

Pump the brakes on CLB β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on CLB, but look at what you are paying: 16.1x trailing P/E with 20.7% gross margins. Unless Core Laboratories Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

TA TapeReader_Pro Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $13.31 (+28.0%)
Spot @ $10.40

CLB cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on CLB, the market is fixating on short-term headline noise in Oilfield Services/Equipment and ignoring the balance sheet and cash flow trajectory. At $10.40 (52-wk range $9.13 - $20.36), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%